Zydus Lifesciences Limited have approved the following special resolutions for: Appointment of Mr. Akhil Monappa (DIN: 09784366) as an Independent Director of the Company for the first term of five consecutive years effective November 29, 2022 and Appointment of Ms. Upasana Kamineni Konidela (DIN: 02781278) as an Independent Director of the Company for the first term of five consecutive years effective November 29, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,076 INR | -0.93% | +2.34% | +56.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.12% | 13.04B | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
-10.73% | 6.72B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.31% | 4.84B | |
+15.91% | 4.27B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Limited Approves Executive Changes